Integrated Wealth Management (Palm Desert)’s GSK GSK Stock Holding History

Integrated Wealth Management (Palm Desert)’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$208K	Buy	+3,953	New	+$201K	0.07%	248
2016 Q4	–	Sell	-3,827	Closed	-$206K	–	551
2016 Q3	$206K	Sell	3,827 -642	-14%	-$35.2K	0.07%	222
2016 Q2	$242K	Buy	4,469 +840	+23%	+$44.3K	0.09%	189
2016 Q1	$184K	Sell	3,629 -617	-15%	-$30.7K	0.08%	200
2015 Q4	$214K	Buy	4,246 +71	+2%	+$3.62K	0.09%	177
2015 Q3	$201K	Sell	4,175 -484	-10%	-$25.2K	0.09%	182
2015 Q2	$243K	Buy	4,659 +695	+18%	+$39.1K	0.09%	164
2015 Q1	$228K	Buy	+3,964	New	+$227K	0.1%	164

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Integrated Wealth Management (Palm Desert)'s GSK Position: Q1 2017 in Review

Integrated Wealth Management (Palm Desert) opened a new position in GSK (GSK) in Q1 2017: 3,953 shares worth $208K. The stake represents 0.07% of the portfolio and ranks #248 among its holdings. This is a return to the name: Integrated Wealth Management (Palm Desert) previously reported a position in GSK as recently as Q3 2016.

Integrated Wealth Management (Palm Desert) first reported a position in GSK in Q1 2015 and has held it in 8 quarters since. The position peaked at $243K in Q2 2015. 787 funds tracked by Wall St. Rank hold GSK as of Q1 2017.

Integrated Wealth Management (Palm Desert) held 3,953 shares of GSK worth $208K as of Q1 2017.
GSK was a new Integrated Wealth Management (Palm Desert) position in Q1 2017.
GSK made up 0.07% of Integrated Wealth Management (Palm Desert)'s portfolio in Q1 2017, its #248 holding.
Integrated Wealth Management (Palm Desert) first reported a position in GSK in Q1 2015 and has held it in 8 quarters since.
Integrated Wealth Management (Palm Desert)'s GSK position peaked at $243K in Q2 2015.
787 funds tracked by Wall St. Rank held GSK as of Q1 2017.

Based on Integrated Wealth Management (Palm Desert)'s 13F filing for Q1 2017, filed 14 Apr 2017.